Budget Implementation Act, 2019, No. 1 (S.C. 2019, c. 29)

DIVISION 6R.S., c. C-8Canada Pension Plan

Amendments to the Act

153 [Amendments]

154 [Amendments]

Coming into Force

Marginal note:January 1, 2020

155 This Division comes into force on January 1, 2020.

DIVISION 7R.S., c. O-9Old Age Security Act

156 [Amendments]

DIVISION 8Non-permitted Surplus

R.S., c. C-17Canadian Forces Superannuation Act

157 [Amendments]

R.S., c. P-36Public Service Superannuation Act

158 [Amendments]

R.S., c. R-11Royal Canadian Mounted Police Superannuation Act

159 [Amendments]

DIVISION 9Regulatory Modernization

SUBDIVISION AR.S., c. B-3; 1992, c. 27, s. 2Bankruptcy and Insolvency Act

160 [Amendments]

161 [Amendments]

SUBDIVISION BR.S., c. E-4Electricity and Gas Inspection Act

162 [Amendments]

SUBDIVISION CR.S., c. F-27Food and Drugs Act

Amendments to the Act

163 [Amendments]

164 [Amendments]

165 [Amendments]

166 [Amendments]

167 [Amendments]

168 [Amendments]

169 [Amendments]

170 [Amendments]

171 [Amendments]

172 [Amendments]

173 [Amendments]

174 [Amendments]

175 [Amendments]

176 [Amendments]

177 [Amendments]

178 [Amendments]

179 [Amendments]

Transitional Provisions

Marginal note:Clinical trials — certain drugs

180 A person that, immediately before the coming into force of section 166, is authorized under Division 5 of Part C of the Food and Drug Regulations to sell or import a drug for the purposes of a clinical trial is deemed to be the holder, in respect of that drug, of an authorization referred to in section 3.1 of the Food and Drugs Act, as enacted by that section 166.

Marginal note:Studies — positron-emitting radiopharmaceuticals

181 A person that, immediately before the coming into force of section 166, is authorized under Division 3 of Part C of the Food and Drug Regulations to sell or import a positron-emitting radiopharmaceutical for the purposes of a study is deemed to be the holder, in respect of that positron-emitting radiopharmaceutical, of an authorization referred to in section 3.1 of the Food and Drugs Act, as enacted by that section 166.

Marginal note:Clinical trials — natural health products

182 A person that, immediately before the coming into force of section 166, is authorized under Part 4 of the Natural Health Products Regulations to sell or import a natural health product for the purposes of a clinical trial is deemed to be the holder, in respect of that natural health product, of an authorization referred to in section 3.1 of the Food and Drugs Act, as enacted by that section 166.

Marginal note:Investigational testing — certain medical devices

183 A person that, immediately before the coming into force of section 166, is authorized under Part 3 of the Medical Devices Regulations to sell or import a Class II, III or IV medical device for investigational testing is deemed to be the holder, in respect of the device, of an authorization referred to in section 3.1 of the Food and Drugs Act, as enacted by that section 166.

Coming into Force

Marginal note:Order in council

Footnote ^*184 Subsections 163(2) and (4), section 166 and subsections 168(2), 172(2), (7) and (8), 173(2), 174(2) and 175(2) come into force on a day to be fixed by order of the Governor in Council.

• Return to footnote ^*[Note: Subsections 163(2) and (4), section 166 and subsections 168(2), 172(2), (7) and (8), 173(2), 174(2) and 175(2) in force May 23, 2020, see SI/2020-39.]

SUBDIVISION DR.S., c. I-3Importation of Intoxicating Liquors Act

185 [Amendments]

186 [Amendments]

187 [Amendments]

188 [Amendments]

189 [Amendments]

SUBDIVISION ER.S., c. P-19Precious Metals Marking Act

190 [Amendments]

SUBDIVISION FR.S., c. T-10Textile Labelling Act

191 [Amendments]

SUBDIVISION GR.S., c. W-6Weights and Measures Act

Amendments to the Act

192 [Amendments]

193 [Amendments]

194 [Amendments]

195 [Amendments]

196 [Amendments]

Coming into Force

Marginal note:May 20, 2019 or royal assent

Footnote ^*197 Section 196 comes into force on the later of May 20, 2019 and the day on which this Act receives royal assent.

• Return to footnote ^*[Note: Section 196 in force on assent June 21, 2019.]

SUBDIVISION HR.S., c. 24 (3rd Supp.), Part IIIHazardous Materials Information Review Act

Amendments to the Act

198 [Amendments]

199 [Amendments]

200 [Amendments]

201 [Amendments]

202 [Amendments]

203 [Amendments]

204 [Amendments]

205 [Amendments]

Transitional Provisions

Marginal note:Definitions

206 The following definitions apply in sections 207 to 210.

affected party

affected party has the meaning assigned by subsection 10(1) of the Hazardous Materials Information Review Act as that subsection read immediately before the day on which subsection 198(1) of this Act comes into force. (partie touchée)

Chief Screening Officer

Chief Screening Officer has the meaning assigned by subsection 10(1) of the Hazardous Materials Information Review Act as that subsection read immediately before the day on which subsection 198(1) of this Act comes into force. (agent de contrôle en chef)

commencement day

commencement day means the day on which section 201 comes into force. (date de référence)

Marginal note:Pending claims for exemption

207 A claim for exemption under the Hazardous Materials Information Review Act that, immediately before the commencement day, was pending before the Chief Screening Officer or before a screening officer assigned under paragraph 12(1)(b) of that Act, as that paragraph read immediately before the commencement day, to review the claim and the safety data sheet or label to which it relates is to be taken up before the Minister of Health and continued in accordance with that Act as it reads on that day.

Marginal note:Appeals

208 An appeal that was filed, before the commencement day, in accordance with section 20 of the Hazardous Materials Information Review Act, as that section read immediately before the commencement day, is continued in accordance with sections 20 to 27 and 43 and 44 of that Act as those sections read immediately before that day.

Marginal note:Liability

209 Section 50 of the Hazardous Materials Information Review Act, as that section read immediately before the day on which section 205 of this Act comes into force, continues to apply to members of an appeal board who are exercising their powers or performing their duties or functions in relation to an appeal that is continued under section 208 of this Act.

Marginal note:Representations

210 If, before the commencement day, a notice was published in the Canada Gazette in accordance with paragraph 12(1)(a) of the Hazardous Materials Information Review Act, as that paragraph read immediately before that day, and section 201 of this Act comes into force before the end of the period specified in the notice, an affected party that wishes to make written representations with respect to the claim for exemption in question and the safety data sheet or label to which it relates may, within the period specified in the notice but on or after the commencement day, make those representations to the Minister of Health.

Coordinating Amendments

211 [Amendments]

212 [Amendments]

Coming into Force

Marginal note:Order in council

Footnote ^*213 The provisions of this Subdivision, other than sections 206 to 212, come into force on a day or days to be fixed by order of the Governor in Council.

• Return to footnote ^*[Note: The provisions of Subdivision H, other than sections 206 to 212, in force March 18, 2020, see SI/2020-20.]

SUBDIVISION I1996, c. 10Canada Transportation Act

Amendments to the Act

214 [Amendments]

215 [Amendments]

Coming into Force

Marginal note:Order in council

Footnote ^*216 Section 215 comes into force on a day to be fixed by order of the Governor in Council.

• Return to footnote ^*[Note: Section 215 in force June 10, 2020, see SI/2020-38.]

SUBDIVISION J2002, c. 28Pest Control Products Act

217 [Amendments]

218 [Amendments]

219 [Amendments]

SUBDIVISION K2005, c. 20Quarantine Act

220 [Amendments]

SUBDIVISION L2009, c. 24Human Pathogens and Toxins Act

221 [Amendments]